相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PharmVar GeneFocus: CYP2D6
Charity Nofziger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry
Lisa Brown et al.
PHARMACOPSYCHIATRY (2020)
Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
Olivia M. Dong et al.
VALUE IN HEALTH (2020)
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy
J. Kevin Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Clinical Pharmacology Education - The Decade Ahead
Kim L. R. Brouwer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
Kelly E. Caudle et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Integrating pharmacogenomics into the electronic health record by implementing genomic indicators
Pedro J. Caraballo et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2020)
Predicting inadequate postoperative pain management in depressed patients: A machine learning approach
Arjun Parthipan et al.
PLOS ONE (2019)
Pharmacy students' attitudes and perceptions toward pharmacogenomics education
Shanice Coriolan et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)
Recommendations for Clinical CYP2C9 Genotyping Allele Selection A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey
Natasa Karas Kuzelicki et al.
PHARMACOGENOMICS (2019)
Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1)
Ken Konaka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
Gwendolin S. Simper et al.
PHARMACEUTICS (2019)
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
D. Max Smith et al.
GENETICS IN MEDICINE (2019)
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients - a randomized, prospective study
Tereza Ruzickova et al.
PHARMACOGENOMICS JOURNAL (2019)
On the readiness of physicians for pharmacogenomics testing: an empirical assessment
N. Amara et al.
PHARMACOGENOMICS JOURNAL (2018)
Education and Knowledge in Pharmacogenomics: Still a Challenge?
Jyothsna Giri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
Matthew P. Goetz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
Elizabeth J. Phillips et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care
Stephany Tandy-Connor et al.
GENETICS IN MEDICINE (2018)
Recommendations for Clinical CYP2C19 Genotyping Allele Selection A Report of the Association for Molecular Pathology
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Analytical validation of a psychiatric pharmacogenomic test
Michael R. Jablonski et al.
PERSONALIZED MEDICINE (2018)
A retrospective investigation of HLA-B*5801 in hyperuricemia patients in a Han population of China
Heng Cheng et al.
PHARMACOGENETICS AND GENOMICS (2018)
Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward
Kelly E. Caudle et al.
PHARMACOGENOMICS (2018)
Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools
Chad A. Bousman et al.
PHARMACOGENOMICS JOURNAL (2018)
Insurance coverage for genomic tests
Kathryn A. Phillips et al.
SCIENCE (2018)
PharmGKB: A worldwide resource for pharmacogenomic information
Julia M. Barbarino et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2018)
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
Robert G. Micheletti et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
User considerations in assessing pharmacogenomic tests and their clinical support tools
Gouri Mukerjee et al.
NPJ GENOMIC MEDICINE (2018)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
Ursula Amstutz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
Liewei Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Multidisciplinary model to implement pharmacogenomics at the point of care
Pedro J. Caraballo et al.
GENETICS IN MEDICINE (2017)
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
Kelly E. Caudle et al.
GENETICS IN MEDICINE (2017)
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty The GIFT Randomized Clinical Trial
Brian F. Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Pharmacogenomics competencies in pharmacy practice: A blueprint for change
Mary W. Roederer et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2017)
Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now
Kristin W. Weitzel et al.
PHARMACEUTICAL RESEARCH (2017)
Methods to analyze big data in pharmacogenomics research
Ruowang Li et al.
PHARMACOGENOMICS (2017)
Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory
Teresa T. Vo et al.
PHARMACOTHERAPY (2017)
Collaborative Counseling Considerations for Pharmacogenomic Tests
Heather A. Zierhut et al.
PHARMACOTHERAPY (2017)
Trends in Tramadol: Pharmacology, Metabolism, and Misuse
Karen Miotto et al.
ANESTHESIA AND ANALGESIA (2017)
Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts
P. J. Caraballo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
Catherine Butkus Small et al.
BMC INFECTIOUS DISEASES (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing
R. S. Gammal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L. V. Kalman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
Henry M. Dunnenberger et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Educational strategies to enable expansion of pharmacogenomics-based care
Kristin Wiisanen Weitzel et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Integrating pharmacogenomics into electronic health records with clinical decision support
J. Kevin Hicks et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome
Yoshihiro Maruo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Race influences warfarin dose changes associated with genetic factors
Nita A. Limdi et al.
BLOOD (2015)
Addressing phenoconversion: the Achilles' heel of personalized medicine
Rashmi R. Shah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K. A. Birdwell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Pharmacogenomics and Implications for Nursing Practice
Dennis J. Cheek et al.
JOURNAL OF NURSING SCHOLARSHIP (2015)
Academic and professional pharmacy education: a pharmacogenomics certificate training program
David F. Kisor et al.
PERSONALIZED MEDICINE (2015)
Clinical Perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 Guidelines for CYP2D6 and Codeine
Wayne T. Nicholson et al.
CLINICAL CHEMISTRY (2015)
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications
Lucio Luzzatto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
J. Kevin Hicks et al.
CURRENT DRUG METABOLISM (2014)
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Kelly E. Caudle et al.
CURRENT DRUG METABOLISM (2014)
Development and use of active clinical decision support for preemptive pharmacogenomics
Gillian C. Bell et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2014)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M. S. Hershfield et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics
C. M. Blake et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
Daniel K. Hall-Flavin et al.
PHARMACOGENETICS AND GENOMICS (2013)
Pharmacogenetics: What PAs need to understand and why
LAWRENCE CAREY
JAAPA-Journal of the American Academy of Physician Assistants (2013)
A role for genetic counsellors and clinical geneticists in pharmacogenetics?
W. G. Newman et al.
CLINICAL GENETICS (2012)
The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics
P. H. O'Donnell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Assessment of the Pharmacogenomics Educational Needs of Pharmacists
Kristen B. McCullough et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2011)
Pharmacogenetics: From Bench to Byte-An Update of Guidelines
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Using pharmacogenetics to understand adverse drug reactions in children
Kaitlyn Shaw et al.
PAEDIATRICS & CHILD HEALTH (2011)
Pharmacogenomics in the Curricula of Colleges and Schools of Pharmacy in the United States
John E. Murphy et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2010)
Characterization of 107 Genomic DNA Reference Materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1 A GeT-RM and Association for Molecular Pathology Collaborative Project
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine
James S. Green et al.
PHARMACOGENOMICS (2010)
The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology
Colin J. D. Ross et al.
THYROID (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
分享论文
